101 related articles for article (PubMed ID: 9549347)
1. [Delivery of macromolecular drugs to the vitreous and its peripheral tissues].
Morita Y; Saino H; Tojo K
Nihon Rinsho; 1998 Mar; 56(3):628-31. PubMed ID: 9549347
[TBL] [Abstract][Full Text] [Related]
2. Effect of benzalkonium chloride on transscleral drug delivery.
Okabe K; Kimura H; Okabe J; Kato A; Shimizu H; Ueda T; Shimada S; Ogura Y
Invest Ophthalmol Vis Sci; 2005 Feb; 46(2):703-8. PubMed ID: 15671302
[TBL] [Abstract][Full Text] [Related]
3. In vivo ocular fluorophotometry: delivery of fluoresceinated dextrans via transscleral diffusion in rabbits.
Berezovsky DE; Patel SR; McCarey BE; Edelhauser HF
Invest Ophthalmol Vis Sci; 2011 Sep; 52(10):7038-45. PubMed ID: 21791594
[TBL] [Abstract][Full Text] [Related]
4. Vitreal elimination kinetics of large molecular weight FITC-labeled dextrans in albino rabbits using a novel microsampling technique.
Dias CS; Mitra AK
J Pharm Sci; 2000 May; 89(5):572-8. PubMed ID: 10756322
[TBL] [Abstract][Full Text] [Related]
5. Suprachoroidal delivery in a rabbit ex vivo eye model: influence of drug properties, regional differences in delivery, and comparison with intravitreal and intracameral routes.
Kadam RS; Williams J; Tyagi P; Edelhauser HF; Kompella UB
Mol Vis; 2013; 19():1198-210. PubMed ID: 23734089
[TBL] [Abstract][Full Text] [Related]
6. Injection site and pharmacokinetics after intravitreal injection of immunoglobulin G.
Miura Y; Uematsu M; Teshima M; Suzuma K; Kumagami T; Sasaki H; Kitaoka T
J Ocul Pharmacol Ther; 2011 Feb; 27(1):35-41. PubMed ID: 21182428
[TBL] [Abstract][Full Text] [Related]
7. In vivo brain microdialysis to evaluate FITC-dextran encapsulated immunopegylated nanoparticles.
Bommana MM; Kirthivasan B; Squillante E
Drug Deliv; 2012 Aug; 19(6):298-306. PubMed ID: 22928708
[TBL] [Abstract][Full Text] [Related]
8. Effects of intraocular pressure change on movement of FITC-dextran across vitreous-aqueous interface.
Sugiura Y; Araie M
Jpn J Ophthalmol; 1989; 33(4):441-50. PubMed ID: 2483180
[TBL] [Abstract][Full Text] [Related]
9. A novel design of one-side coated biodegradable intrascleral implant for the sustained release of triamcinolone acetonide.
Kim YM; Lim JO; Kim HK; Kim SY; Shin JP
Eur J Pharm Biopharm; 2008 Sep; 70(1):179-86. PubMed ID: 18667297
[TBL] [Abstract][Full Text] [Related]
10. Feasibility of drug delivery to the posterior pole of the rabbit eye with an episcleral implant.
Kato A; Kimura H; Okabe K; Okabe J; Kunou N; Ogura Y
Invest Ophthalmol Vis Sci; 2004 Jan; 45(1):238-44. PubMed ID: 14691179
[TBL] [Abstract][Full Text] [Related]
11. Ocular tissue distribution of betamethasone after anterior-episcleral, posterior-episcleral, and anterior-intrascleral placement of nonbiodegradable implants.
Okabe K; Kimura H; Okabe J; Ogura Y
Retina; 2007; 27(6):770-7. PubMed ID: 17621189
[TBL] [Abstract][Full Text] [Related]
12. Effects of vitreous liquefaction on the intravitreal distribution of sodium fluorescein, fluorescein dextran, and fluorescent microparticles.
Tan LE; Orilla W; Hughes PM; Tsai S; Burke JA; Wilson CG
Invest Ophthalmol Vis Sci; 2011 Feb; 52(2):1111-8. PubMed ID: 20881289
[TBL] [Abstract][Full Text] [Related]
13. The loss of fluorescein, fluorescein glucuronide and fluorescein isothiocyanate dextran from the vitreous by the anterior and retinal pathways.
Araie M; Maurice DM
Exp Eye Res; 1991 Jan; 52(1):27-39. PubMed ID: 1714398
[TBL] [Abstract][Full Text] [Related]
14. Ocular pharmacokinetics of fluocinolone acetonide following Iluvien implantation in the vitreous humor of rabbits.
Kane FE; Green KE
J Ocul Pharmacol Ther; 2015 Feb; 31(1):11-6. PubMed ID: 25562126
[TBL] [Abstract][Full Text] [Related]
15. Measurement of aqueous flow in rabbits with corneal and vitreous depots of fluorescent dye.
Gaul GR; Brubaker RF
Invest Ophthalmol Vis Sci; 1986 Sep; 27(9):1331-5. PubMed ID: 2427473
[TBL] [Abstract][Full Text] [Related]
16. Biodegradable intrascleral implant for sustained intraocular delivery of betamethasone phosphate.
Okabe J; Kimura H; Kunou N; Okabe K; Kato A; Ogura Y
Invest Ophthalmol Vis Sci; 2003 Feb; 44(2):740-4. PubMed ID: 12556407
[TBL] [Abstract][Full Text] [Related]
17. Pharmacokinetics of intraocular drug delivery by periocular injections using ocular fluorophotometry.
Ghate D; Brooks W; McCarey BE; Edelhauser HF
Invest Ophthalmol Vis Sci; 2007 May; 48(5):2230-7. PubMed ID: 17460284
[TBL] [Abstract][Full Text] [Related]
18. Laser-induced intrachoroidal dexamethasone drug delivery system to posterior eye segment.
Murata M; Sanbe A; Lee JW; Nishigori H
Invest Ophthalmol Vis Sci; 2013 Dec; 54(13):8317-24. PubMed ID: 24265021
[TBL] [Abstract][Full Text] [Related]
19. Dextran retention in the rat brain following release from a polymer implant.
Dang W; Saltzman WM
Biotechnol Prog; 1992; 8(6):527-32. PubMed ID: 1282018
[TBL] [Abstract][Full Text] [Related]
20. The regurgitation of large vitreous injections.
Maurice DM
J Ocul Pharmacol Ther; 1997 Oct; 13(5):461-3. PubMed ID: 9326727
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]